WH
FMI

William Harnisch’s Foundation Medicine, Inc. FMI Stock Holding History

William Harnisch’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-90,147
Closed -$1.6M – 57
2016
Q4 		$1.6M Hold
90,147
– – 0.21% 32
2016
Q3 		$2.1M Buy
+90,147
New +$2.05M 0.27% 28

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

William Harnisch's FMI Position: Q1 2017 in Review

William Harnisch sold out of Foundation Medicine, Inc. (FMI) in Q1 2017, closing a stake of 90,147 shares — an estimated $1.6M sold.

William Harnisch first reported a position in FMI in Q3 2016 and held it in 2 quarters. The position peaked at $2.1M in Q3 2016. 93 funds tracked by Wall St. Rank hold FMI as of Q1 2017.

  • William Harnisch reported no remaining Foundation Medicine, Inc. position as of Q1 2017 after selling out during the quarter.
  • William Harnisch sold 90,147 Foundation Medicine, Inc. shares in Q1 2017, an estimated $1.6M.
  • William Harnisch first reported a position in Foundation Medicine, Inc. in Q3 2016 and held it in 2 quarters.
  • William Harnisch's Foundation Medicine, Inc. position peaked at $2.1M in Q3 2016.
  • 93 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2017.

Based on Peconic Partners's 13F filing for Q1 2017, filed 15 May 2017.